| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1.
|
Science
|
2006
|
7.12
|
|
2
|
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
|
AIDS
|
2006
|
6.46
|
|
3
|
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.
|
Lancet
|
2004
|
4.81
|
|
4
|
Antigenic conservation and immunogenicity of the HIV coreceptor binding site.
|
J Exp Med
|
2005
|
4.68
|
|
5
|
Origin of the human malaria parasite Plasmodium falciparum in gorillas.
|
Nature
|
2010
|
4.35
|
|
6
|
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.
|
AIDS
|
2002
|
4.01
|
|
7
|
Human immunodeficiency viruses: SIV infection in wild gorillas.
|
Nature
|
2006
|
3.35
|
|
8
|
Adherence to HAART and its principal determinants in a cohort of Senegalese adults.
|
AIDS
|
2003
|
3.14
|
|
9
|
Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.
|
J Acquir Immune Defic Syndr
|
2005
|
3.09
|
|
10
|
Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat.
|
Emerg Infect Dis
|
2002
|
2.98
|
|
11
|
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
|
Lancet Infect Dis
|
2011
|
2.82
|
|
12
|
African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum.
|
Proc Natl Acad Sci U S A
|
2010
|
2.60
|
|
13
|
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
|
Clin Infect Dis
|
2013
|
2.53
|
|
14
|
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
|
Lancet Infect Dis
|
2013
|
2.51
|
|
15
|
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon.
|
Virology
|
2007
|
2.01
|
|
16
|
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny.
|
J Virol
|
2002
|
1.99
|
|
17
|
Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal.
|
AIDS
|
2003
|
1.94
|
|
18
|
Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.
|
Virology
|
2003
|
1.76
|
|
19
|
Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.
|
Clin Infect Dis
|
2005
|
1.73
|
|
20
|
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.
|
Antivir Ther
|
2013
|
1.68
|
|
21
|
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade.
|
J Virol
|
2004
|
1.68
|
|
22
|
Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.
|
J Clin Microbiol
|
2009
|
1.65
|
|
23
|
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon.
|
J Virol
|
2003
|
1.61
|
|
24
|
Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
|
Clin Infect Dis
|
2009
|
1.57
|
|
25
|
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
|
AIDS
|
2011
|
1.55
|
|
26
|
Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.
|
J Acquir Immune Defic Syndr
|
2002
|
1.51
|
|
27
|
Prevalence of intestinal parasites including microsporidia in human immunodeficiency virus-infected adults in Cameroon: a cross-sectional study.
|
Am J Trop Med Hyg
|
2006
|
1.48
|
|
28
|
Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.
|
PLoS One
|
2009
|
1.43
|
|
29
|
Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas.
|
J Virol
|
2009
|
1.42
|
|
30
|
Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.
|
J Virol
|
2010
|
1.42
|
|
31
|
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.
|
Antivir Ther
|
2009
|
1.35
|
|
32
|
Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002.
|
J Acquir Immune Defic Syndr
|
2005
|
1.34
|
|
33
|
Simian T-cell leukemia virus (STLV) infection in wild primate populations in Cameroon: evidence for dual STLV type 1 and type 3 infection in agile mangabeys (Cercocebus agilis).
|
J Virol
|
2004
|
1.30
|
|
34
|
Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.
|
Antivir Ther
|
2005
|
1.30
|
|
35
|
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.
|
AIDS Res Hum Retroviruses
|
2009
|
1.25
|
|
36
|
Detection and genetic characterization of enteroviruses circulating among wild populations of chimpanzees in Cameroon: relationship with human and simian enteroviruses.
|
J Virol
|
2011
|
1.23
|
|
37
|
Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping.
|
J Antimicrob Chemother
|
2010
|
1.22
|
|
38
|
No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.
|
J Infect Dis
|
2002
|
1.22
|
|
39
|
High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.
|
J Int AIDS Soc
|
2011
|
1.21
|
|
40
|
CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J.
|
J Acquir Immune Defic Syndr
|
2002
|
1.21
|
|
41
|
Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods.
|
J Acquir Immune Defic Syndr
|
2011
|
1.21
|
|
42
|
Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions.
|
Infect Genet Evol
|
2009
|
1.20
|
|
43
|
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
|
J Clin Microbiol
|
2013
|
1.20
|
|
44
|
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
|
AIDS Res Hum Retroviruses
|
2008
|
1.19
|
|
45
|
Revisiting long-term adherence to highly active antiretroviral therapy in Senegal using latent class analysis.
|
J Acquir Immune Defic Syndr
|
2011
|
1.19
|
|
46
|
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.
|
AIDS
|
2003
|
1.15
|
|
47
|
HIV-1 subtypes and recombinants in the Republic of Congo.
|
Infect Genet Evol
|
2006
|
1.14
|
|
48
|
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.
|
J Acquir Immune Defic Syndr
|
2008
|
1.14
|
|
49
|
A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
|
Trop Med Int Health
|
2007
|
1.13
|
|
50
|
Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.
|
J Acquir Immune Defic Syndr
|
2004
|
1.13
|
|
51
|
HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure.
|
AIDS
|
2004
|
1.11
|
|
52
|
Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
|
Expert Opin Drug Saf
|
2008
|
1.10
|
|
53
|
Full-length genome characterization of a novel simian immunodeficiency virus lineage (SIVolc) from olive Colobus (Procolobus verus) and new SIVwrcPbb strains from Western Red Colobus (Piliocolobus badius badius) from the Tai Forest in Ivory Coast.
|
J Virol
|
2008
|
1.09
|
|
54
|
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.
|
Antivir Ther
|
2006
|
1.09
|
|
55
|
Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
|
J Acquir Immune Defic Syndr
|
2009
|
1.08
|
|
56
|
Antiretroviral drug resistance and routine therapy, Cameroon.
|
Emerg Infect Dis
|
2006
|
1.08
|
|
57
|
Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.
|
J Int AIDS Soc
|
2013
|
1.07
|
|
58
|
Identification and molecular characterization of new STLV-1 and STLV-3 strains in wild-caught nonhuman primates in Cameroon.
|
Virology
|
2007
|
1.07
|
|
59
|
Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.
|
J Int AIDS Soc
|
2012
|
1.05
|
|
60
|
Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort.
|
J Acquir Immune Defic Syndr
|
2013
|
1.05
|
|
61
|
Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
|
J Antimicrob Chemother
|
2013
|
1.05
|
|
62
|
Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China.
|
AIDS Res Hum Retroviruses
|
2008
|
1.04
|
|
63
|
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
|
J Clin Virol
|
2006
|
1.03
|
|
64
|
Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China.
|
AIDS
|
2009
|
1.03
|
|
65
|
Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from Western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus).
|
J Virol
|
2003
|
1.03
|
|
66
|
Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages.
|
Virology
|
2006
|
1.02
|
|
67
|
Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay.
|
Emerg Infect Dis
|
2011
|
1.02
|
|
68
|
Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.
|
J Acquir Immune Defic Syndr
|
2011
|
1.02
|
|
69
|
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.
|
AIDS
|
2007
|
1.01
|
|
70
|
Widely varying SIV prevalence rates in naturally infected primate species from Cameroon.
|
Virology
|
2005
|
1.01
|
|
71
|
Prevalence of HIV and other sexually transmitted infections, and risk behaviours in unregistered sex workers in Dakar, Senegal.
|
AIDS
|
2003
|
1.01
|
|
72
|
Molecular evidence for the presence of Rickettsia Felis in the feces of wild-living African apes.
|
PLoS One
|
2013
|
1.01
|
|
73
|
High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity.
|
J Clin Microbiol
|
2011
|
0.99
|
|
74
|
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d'Ivoire.
|
AIDS
|
2013
|
0.99
|
|
75
|
Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria.
|
Proc Natl Acad Sci U S A
|
2013
|
0.98
|
|
76
|
Prevalence and genetic diversity of simian immunodeficiency virus infection in wild-living red colobus monkeys (Piliocolobus badius badius) from the Taï forest, Côte d'Ivoire SIVwrc in wild-living western red colobus monkeys.
|
Infect Genet Evol
|
2007
|
0.98
|
|
77
|
Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients.
|
FEMS Immunol Med Microbiol
|
2006
|
0.97
|
|
78
|
Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.
|
Retrovirology
|
2011
|
0.97
|
|
79
|
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2).
|
AIDS Res Hum Retroviruses
|
2004
|
0.97
|
|
80
|
Full molecular characterization of a simian immunodeficiency virus, SIVwrcpbt from Temminck's red colobus (Piliocolobus badius temminckii) from Abuko Nature Reserve, The Gambia.
|
Virology
|
2008
|
0.97
|
|
81
|
Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.
|
AIDS Res Hum Retroviruses
|
2008
|
0.96
|
|
82
|
Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort.
|
BMC Infect Dis
|
2010
|
0.95
|
|
83
|
Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon.
|
J Acquir Immune Defic Syndr
|
2004
|
0.93
|
|
84
|
High genetic diversity of HIV-1 strains in Chad, West Central Africa.
|
J Acquir Immune Defic Syndr
|
2003
|
0.93
|
|
85
|
Molecular characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis).
|
Virology
|
2006
|
0.92
|
|
86
|
Access to antiretroviral drugs and AIDS management in Senegal.
|
AIDS
|
2003
|
0.92
|
|
87
|
Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa.
|
AIDS Res Hum Retroviruses
|
2002
|
0.92
|
|
88
|
Political and socioeconomic instability: how does it affect HIV? A case study in the Democratic Republic of Congo.
|
AIDS
|
2004
|
0.92
|
|
89
|
HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi.
|
AIDS Res Hum Retroviruses
|
2007
|
0.92
|
|
90
|
Origin and diversity of human retroviruses.
|
AIDS Rev
|
2014
|
0.92
|
|
91
|
Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
|
AIDS Res Hum Retroviruses
|
2010
|
0.92
|
|
92
|
Change over time of mortality predictors after HAART initiation in a Senegalese cohort.
|
Eur J Epidemiol
|
2008
|
0.91
|
|
93
|
Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo.
|
AIDS Res Hum Retroviruses
|
2011
|
0.91
|
|
94
|
Commercial logging and HIV epidemic, rural Equatorial Africa.
|
Emerg Infect Dis
|
2004
|
0.90
|
|
95
|
Ubiquitous Hepatocystis infections, but no evidence of Plasmodium falciparum-like malaria parasites in wild greater spot-nosed monkeys (Cercopithecus nictitans).
|
Int J Parasitol
|
2012
|
0.90
|
|
96
|
Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon.
|
J Virol
|
2012
|
0.89
|
|
97
|
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
|
BMC Public Health
|
2010
|
0.89
|
|
98
|
Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo.
|
J Acquir Immune Defic Syndr
|
2016
|
0.88
|
|
99
|
Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
|
Antivir Ther
|
2011
|
0.88
|
|
100
|
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
|
Antivir Ther
|
2010
|
0.87
|
|
101
|
Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial.
|
J Acquir Immune Defic Syndr
|
2013
|
0.87
|
|
102
|
Co-circulation of enteroviruses between apes and humans.
|
J Gen Virol
|
2013
|
0.85
|
|
103
|
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
|
J Acquir Immune Defic Syndr
|
2015
|
0.85
|
|
104
|
CRF45_AKU, a circulating recombinant from Central Africa, is probably the common ancestor of HIV type 1 MAL and HIV type 1 NOGIL.
|
AIDS Res Hum Retroviruses
|
2009
|
0.85
|
|
105
|
Molecular epidemiology of human immunodeficiency virus type 1 in Guangdong province of southern China.
|
PLoS One
|
2012
|
0.85
|
|
106
|
Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients.
|
Mycoses
|
2014
|
0.84
|
|
107
|
Phylogenetic analysis of Brazilian HIV type 1 subtype D strains: tracing the origin of this subtype in Brazil.
|
AIDS Res Hum Retroviruses
|
2006
|
0.84
|
|
108
|
Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.
|
J Clin Microbiol
|
2002
|
0.84
|
|
109
|
Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France.
|
AIDS Res Hum Retroviruses
|
2008
|
0.84
|
|
110
|
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
|
Antivir Ther
|
2013
|
0.84
|
|
111
|
Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa.
|
AIDS Res Hum Retroviruses
|
2005
|
0.84
|
|
112
|
Call for action to secure universal access to ART in developing countries.
|
Lancet
|
2010
|
0.84
|
|
113
|
High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo.
|
AIDS Res Hum Retroviruses
|
2010
|
0.84
|
|
114
|
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.
|
AIDS
|
2015
|
0.84
|
|
115
|
High frequency of HIV-1 infections with multiple HIV-1 strains in men having sex with men (MSM) in Senegal.
|
Infect Genet Evol
|
2013
|
0.83
|
|
116
|
CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso.
|
AIDS
|
2003
|
0.83
|
|
117
|
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
|
AIDS Res Hum Retroviruses
|
2014
|
0.83
|
|
118
|
Genetic diversity of simian lentivirus in wild De Brazza's monkeys (Cercopithecus neglectus) in Equatorial Africa.
|
J Gen Virol
|
2010
|
0.83
|
|
119
|
Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon.
|
J Gen Virol
|
2010
|
0.83
|
|
120
|
Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U.
|
AIDS Res Hum Retroviruses
|
2009
|
0.83
|
|
121
|
Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa.
|
AIDS Res Hum Retroviruses
|
2005
|
0.83
|
|
122
|
HIV and hepatitis C virus coinfection, Cameroon.
|
Emerg Infect Dis
|
2007
|
0.83
|
|
123
|
High rates of infection with novel enterovirus variants in wild populations of mandrills and other old world monkey species.
|
J Virol
|
2014
|
0.83
|
|
124
|
Predominance of CRF02-AG and CRF06-cpx in Niger, West Africa.
|
AIDS Res Hum Retroviruses
|
2002
|
0.82
|
|
125
|
Emergence of complex and diverse CRF02-AG/CRF06-cpx recombinant HIV type 1 strains in Niger, West Africa.
|
AIDS Res Hum Retroviruses
|
2003
|
0.82
|
|
126
|
Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals.
|
PLoS One
|
2013
|
0.82
|
|
127
|
Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).
|
PLoS One
|
2013
|
0.81
|
|
128
|
Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial.
|
PLoS One
|
2012
|
0.81
|
|
129
|
A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa.
|
Infect Genet Evol
|
2012
|
0.80
|
|
130
|
Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors.
|
ISRN AIDS
|
2012
|
0.80
|
|
131
|
WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations.
|
Trop Med Int Health
|
2010
|
0.80
|
|
132
|
Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.
|
AIDS
|
2015
|
0.80
|
|
133
|
High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid.
|
AIDS
|
2003
|
0.80
|
|
134
|
Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon.
|
Clin Infect Dis
|
2013
|
0.79
|
|
135
|
Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.
|
PLoS One
|
2012
|
0.79
|
|
136
|
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.
|
MedGenMed
|
2007
|
0.79
|
|
137
|
HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains.
|
AIDS Res Hum Retroviruses
|
2013
|
0.79
|
|
138
|
[Genetic diversity and phylogeographic distribution of SIV: how to understand the origin of HIV].
|
Med Sci (Paris)
|
2008
|
0.78
|
|
139
|
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings.
|
BMC Infect Dis
|
2012
|
0.78
|
|
140
|
Nonhuman primate retroviruses from Cambodia: high simian foamy virus prevalence, identification of divergent STLV-1 strains and no evidence of SIV infection.
|
Infect Genet Evol
|
2013
|
0.78
|
|
141
|
Successful integrase inhibitor-based highly active antiretroviral therapy for a multidrug-class-resistant HIV type 1 group O-infected patient in Cameroon.
|
AIDS Res Hum Retroviruses
|
2012
|
0.78
|
|
142
|
Lack of Evidence of Simian Immunodeficiency Virus Infection Among Nonhuman Primates in Taï National Park, Côte d'Ivoire: Limitations of Noninvasive Methods and SIV Diagnostic Tools for Studies of Primate Retroviruses.
|
Int J Primatol
|
2011
|
0.78
|
|
143
|
Universal health coverage and HIV in resource-constrained countries: a critical juncture for research and action.
|
AIDS
|
2013
|
0.78
|
|
144
|
Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon.
|
J Public Health Policy
|
2012
|
0.77
|
|
145
|
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
|
AIDS
|
2016
|
0.77
|
|
146
|
Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial.
|
AIDS Care
|
2013
|
0.76
|
|
147
|
[HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
|
Gastroenterol Clin Biol
|
2002
|
0.76
|
|
148
|
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.
|
J Int AIDS Soc
|
2007
|
0.75
|
|
149
|
Failure to detect simian immunodeficiency virus infection in a large Cameroonian cohort with high non-human primate exposure.
|
Ecohealth
|
2012
|
0.75
|
|
150
|
Assessment of gastrointestinal parasites in wild chimpanzees (Pan troglodytes troglodytes) in southeast Cameroon.
|
Parasitol Res
|
2014
|
0.75
|
|
151
|
Laboratory monitoring for antiretroviral therapy in low-resource settings.
|
Lancet Infect Dis
|
2013
|
0.75
|
|
152
|
High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
153
|
Nonlinear multiple imputation for continuous covariate within semiparametric Cox model: application to HIV data in Senegal.
|
Stat Med
|
2013
|
0.75
|
|
154
|
Antiretroviral drugs in Africa: a public health versus a market approach.
|
J Acquir Immune Defic Syndr
|
2013
|
0.75
|
|
155
|
Role of Wildlife in Emergence of Ebola Virus in Kaigbono (Likati), Democratic Republic of the Congo, 2017.
|
Emerg Infect Dis
|
2020
|
0.75
|
|
156
|
Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
|
Trop Med Int Health
|
2010
|
0.75
|